You are here

Article info

Article menu

Download PDFPDF

Editorial
Clinical trials of biosimilars should become more similar
Free

Authors

  • Jonathan Kay Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, Massachusetts, USA PubMed articlesGoogle scholar articles
  • John D Isaacs Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University and National Institute of Health Research Newcastle Biomedical Research Centre, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Jonathan Kay, Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Memorial Campus, 119 Belmont Street, Worcester, MA 01605, USA; jonathan.kay{at}umassmemorial.org
View Full Text

Citation

Kay J, Isaacs JD
Clinical trials of biosimilars should become more similar
Annals of the Rheumatic Diseases 2017;76:4-6.

Publication history

  • Received June 27, 2016
  • Revised July 18, 2016
  • Accepted July 31, 2016
  • First published August 25, 2016.
Online issue publication 
November 02, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/